Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies. Cala Health’s lead product, Cala Trio™, is the only non-invasive prescription therapy for essential tremor. New therapies are under development in neurology, cardiology and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
About Cala™



In The News

Electricity as Medicine: Lux Capital's Josh Wolfe and Cala Health CEO Renee Ryan
Lux Capital Managing Partner and Co-Founder Josh Wolfe visits the headquarters of Lux portfolio company Cala Health in Burlingame, California and has a conversation with CEO Renee Ryan. You’ll get an inside look at how Cala is empowering people with chronic disease.

Cala Health named A GOLD WINNER of the 2020 Edison Awards
Cala Trio therapy took the GOLD award for Diagnostics & Disease Treatment in the Medical Device/Dental category. Among the nomination entries comprising the best products, services, and businesses in innovation for the year 2020, Cala Trio was chosen as a winner by a panel of over 3,000 leading business executives from around the world.

Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio™
Based on its recent analysis of the North American essential tremor (ET) treatment market, Frost & Sullivan recognizes Cala Health, Inc. with the 2019 North American Technology Innovation Award for its Cala Trio™, a prescription-only, wrist-worn device.
Meet the Team






Join the Team
Cala Health believes our success is based on diversity of people, teams and thinking. We offer all employees the tools, training and mentoring they need to succeed. Our selection process is driven by the key requirements for the role rather than bias or discrimination on the basis of a candidate’s sex, gender identity, age, marital status, veteran status, non-job-related disability/handicap or medical condition, family status, sexual orientation, religion, color, ethnicity, race or any other legally protected classification.

Problem-Solving Mindset
Building a new category of therapies requires breakthrough thinking. Intense curiosity drives us to discover and design life-changing solutions.

Collaborative Culture
Talented people thrive in passionate, inclusive teams where every team member matters. We inspire each other to make the impossible possible.

Building the Future
We are delivering innovative therapies at the cutting-edge of technology and neuroscience. We believe non-invasive electrical medicines will change the face of healthcare.